The Central Role of Echocardiography in Mavacamten Therapy for Obstructive Hypertrophic Cardiomyopathy: A

Ali Nizam1, Ibrahim Antoun1,2, Liz Hodson1

  • 1Department of Cardiology, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK, nhs.uk.

Insights

Mavacamten therapy for obstructive hypertrophic cardiomyopathy (HCM) relies heavily on echocardiography for patient selection and monitoring. Standardized echocardiographic assessments are crucial for effective mavacamten treatment and accurate physiological response evaluation.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Pharmacology

Background:

  • Obstructive hypertrophic cardiomyopathy (HCM) is a significant cardiovascular condition.
  • Mavacamten, a cardiac myosin inhibitor, offers a therapeutic option for symptomatic obstructive HCM.
  • Echocardiography plays a pivotal role in the management of patients treated with mavacamten.

Purpose of the Study:

  • To provide a practical echocardiographic approach for mavacamten therapy.
  • To emphasize key echocardiographic parameters for patient selection, monitoring, and dose titration.
  • To discuss current regulatory requirements and unresolved issues in echocardiographic assessment for mavacamten.

Main Methods:

  • Narrative review of echocardiographic practices in mavacamten therapy.
  • Focus on reproducible left ventricular outflow tract (LVOT) gradient assessment.
  • Inclusion of Valsalva manoeuvres, LVEF monitoring, and assessment of mitral valve dynamics.

Main Results:

  • Echocardiography is essential for identifying suitable patients and guiding mavacamten treatment.
  • Regulatory guidelines mandate specific echocardiographic monitoring during titration and maintenance.
  • Standardized echocardiographic acquisition and reporting are vital for reliable treatment decisions.

Conclusions:

  • A standardized echocardiographic approach is necessary for effective mavacamten therapy in obstructive HCM.
  • Consistent monitoring ensures treatment decisions reflect true physiological response.
  • Further research is needed for exercise echocardiography and other emerging parameters in mavacamten management.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...